Opendata, web and dolomites

iPS-ChOp-AF SIGNED

Combining induced pluripotent stem cells, tissue engineering, optogenetic and chemogenetic concepts for the study and treatment of atrial fibrillation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iPS-ChOp-AF project word cloud

Explore the words cloud of the iPS-ChOp-AF project. It provides you a very rough idea of what is the project "iPS-ChOp-AF" about.

insights    engineered    ligand    chemogenetics    purified    cell    mortality    rotors    technologies    sensitive    2d    animal    heart    developmental    paucity    sheet    rhythm    yield    crispr    reversible    editing    perturbations    protocols    optogenetics    road    optogenetic    disorders    hipsc    3d    hydrogels    gain    tissue    biology    mechanistic    treat    patient    functional    combine    differentiation    inability    strategies    atrial    inherited    reflecting    genetic    therapeutic    printing    stem    human    hampered    re    responsible    tools    channels    arrhythmias    perform    light    differentiating    morbidity    pathogenesis    ing    disease    arrhythmia    experimental    ion    electrophysiological    genome    therapies    receptors    lack    decellularization    paradigms    treatment    models    engineering    cardiac    inspired    shift    fibrillation    pluripotent    plan    chemogenetic    pumps    resolution    af    abnormalities    utilize    acquired    entry    manipulation    treatments    chamber    cells    paradigm   

Project "iPS-ChOp-AF" data sheet

The following table provides information about the project.

Coordinator
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY 

Organization address
address: SENATE BUILDING TECHNION CITY
city: HAIFA
postcode: 32000
website: www.technion.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 1˙988˙750 €
 EC max contribution 1˙988˙750 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-COG
 Funding Scheme ERC-COG
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2023-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY IL (HAIFA) coordinator 1˙988˙750.00

Map

 Project objective

'Cardiac arrhythmias are responsible for significant morbidity and mortality. However, the study and treatment of these rhythm disorders have been hampered by the lack of relevant human cardiac tissue models, specifically those reflecting patient/disease-specific abnormalities, by paucity of methods for long-term electrophysiological analysis of the tissue, and by the inability to perform targeted, high-resolution, reversible, and functional perturbations of the system. To address these challenges, we propose to combine human induced pluripotent stem cells (hiPSC) and genome-editing (CRISPR) technologies, developmental biology-inspired differentiating systems that yield chamber-specific heart cells, novel tissue engineering strategies, and emerging concepts from the fields of optogenetics and chemogenetics. The resulting experimental models should represent a paradigm shift in the way we study and treat cardiac arrhythmias. To demonstrate the unique potential of this approach, we plan to focus on atrial fibrillation (AF), the most common arrhythmia. Our specific aims are to: 1. Develop patient/disease-specific hiPSC models of genetic AF and to establish hiPSC differentiation protocols to yield purified atrial cells 2. Utilize the hiPSC-atrial cells and advanced tissue-engineering strategies (hydrogels, 3D printing, decellularization) to establish 2D cell-sheet and 3D tissue models of acquired and inherited AF, in which functional re-entry ('rotors') can be studied 3. Utilize tools from optogenetics (light-sensitive ion channels and pumps) or chemogenetics (ligand-specific engineered receptors) for targeted manipulation of the system, to gain insights into AF pathogenesis and to develop novel therapies 4. Evaluate the developed optogenetic and chemogenetic treatments in animal models of AF The results of this project should provide novel mechanistic insights into AF (and other arrhythmias) and open the road for the development of novel therapeutic paradigms.'

 Publications

year authors and title journal last update
List of publications.
2018 Naim Shaheen, Assad Shiti, Irit Huber, Rami Shinnawi, Gil Arbel, Amira Gepstein, Noga Setter, Idit Goldfracht, Amit Gruber, Snizhanna V. Chorna, Lior Gepstein
Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies
published pages: 1879-1894, ISSN: 2213-6711, DOI: 10.1016/j.stemcr.2018.04.006
Stem Cell Reports 10/6 2019-12-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IPS-CHOP-AF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IPS-CHOP-AF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

SUExp (2018)

Strategic Uncertainty: An Experimental Investigation

Read More  

TOROS (2019)

A Theory-Oriented Real-Time Operating System for Temporally Sound Cyber-Physical Systems

Read More  

NanoMechShape (2019)

Molecular control of actin network architecture and mechanics during cell shape changes

Read More